Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
200 participants
INTERVENTIONAL
2021-03-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stimulated Intrauterine Insemination Cycles and Unstimulated Intrauterine Insemination Cycles in Couples With Unexplained Infertility
NCT02461173
Timing of HCG Administration in IUI Cycles
NCT02330705
Study to Assess the Effect of Intrauterine Adminstration of HCG Versus Endometrial Injury by Pipelle
NCT05050747
Intrauterine Injection of Human Chorionic Gonadotrophin and Pregnancy Rate in ICSI
NCT03445910
Efficacy of Letrozole and CC Alone in an IUI Program in Cases With Surgically Treated Minimal to Mild Endometriosis
NCT01334762
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Before trying ICSI, we could help these patients with ANTIUI
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
Will receive ANTIUI protocol
Gonadotropin
Giving patients gonadotropins and antagonist cetrotide
Control group
Will receive standard protocol in IUI and unexplained infertility
Standard protocol in IUI
Giving patients gonadotropins without antagonist cetrotide
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gonadotropin
Giving patients gonadotropins and antagonist cetrotide
Standard protocol in IUI
Giving patients gonadotropins without antagonist cetrotide
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Duration less than 5 years
* Good ovarian reserve AMH\> 1.1
* Normal patent tubes
* No previous trials of IUI with the same protocol
Exclusion Criteria
* Duration of infertility\> 5 years
* Abnormal semen
* Hypoplastic tubes
* prior failed ICSI
20 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayman S Dawood, MD
Assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ayman Shehata Dawood
Tanta, Gharbia Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANTIUI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.